{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T07:55:08Z","timestamp":1766735708820,"version":"3.48.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Crescentic glomerulonephritis, which is mostly recognized due to lupus nephritis, anti-neutrophil cytoplasmic antibody-associated vasculitis, anti-glomerular basement membrane antibody disease, and immune complex-mediated injury, complicates acute kidney disease (AKD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case description<\/jats:title>\n                    <jats:p>A 37\u00a0year-old male patient with oligo-anuric AKD who developed indications for renal replacement therapy secondary to crescentic complement 3 (C3) glomerulopathy was presented. Endocapillary necrotizing crescentic glomerulonephritis with isolated C3 deposition in the kidney biopsy of our patient was confirmed as complement 3 glomerulopathy (C3G). The patient was successfully treated with oral methylprednisolone and 6 doses of monthly parenteral cyclophosphamide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We emphasize the importance of proteinuria evaluation in patients with oligo-anuric AKD even when polyuria phase begins which means that the recovery period of AKD is initiated. Therefore, crescentic C3G should be considered in such patients. Monoclonal gammopathy and genetic factor H defects should be investigated to determine the underlying etiology in C3G patients. Monthly cycles of cyclophosphamide infusion (a total of 6\u00a0cycles) are beneficial for these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/omcr\/omaf269","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T12:28:39Z","timestamp":1762777719000},"source":"Crossref","is-referenced-by-count":0,"title":["A very rare cause of oliguric acute kidney disease: crescentic C3 glomerulopathy"],"prefix":"10.1093","volume":"2025","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4957-465X","authenticated-orcid":false,"given":"K\u00fcbra","family":"Kaynar","sequence":"first","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine, Karadeniz Technical University , Trabzon ,","place":["T\u00fcrkiye"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4757-6299","authenticated-orcid":false,"given":"Aytu\u011f","family":"G\u00fcven","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Karadeniz Technical University , Trabzon ,","place":["T\u00fcrkiye"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0781-4124","authenticated-orcid":false,"given":"Berk","family":"Gen\u00e7celep","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Karadeniz Technical University , Trabzon ,","place":["T\u00fcrkiye"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5964-923X","authenticated-orcid":false,"given":"Tuba","family":"Ertekin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Karadeniz Technical University , Trabzon ,","place":["T\u00fcrkiye"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4882-352X","authenticated-orcid":false,"given":"Sevdeg\u00fcl Ayd\u0131n","family":"Mungan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Karadeniz Technical University , Trabzon ,","place":["T\u00fcrkiye"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"2025122602500764000_ref1","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/ki.1996.380","article-title":"Epidemiology of acute renal failure: a prospective, multicenter, community-based study","volume":"50","author":"Lia\u00f1o","year":"1996","journal-title":"Kidney Int"},{"key":"2025122602500764000_ref2","first-page":"835","volume-title":"Comprehensive Clinical Nephrology","author":"Judd","year":"2024"},{"key":"2025122602500764000_ref3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12882-020-01836-3","article-title":"Glomerulonephritis histopathological pattern change","volume":"21","author":"AlYousef","year":"2020","journal-title":"BMC Nephrol"},{"key":"2025122602500764000_ref4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41581-018-0107-2","article-title":"C3 glomerulopathy understanding a rare complement-driven renal disease","volume":"15","author":"Smith","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"2025122602500764000_ref5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2215\/CJN.04700513","article-title":"C3 glomerulopathy: clinicopathologic features and predictors of outcome","volume":"9","author":"Medjeral-Thomas","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025122602500764000_ref6","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.kint.2017.10.022","article-title":"C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy","volume":"93","author":"Bomback","year":"2018","journal-title":"Kidney Int"},{"key":"2025122602500764000_ref7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/JMAU.JMAU_8_20","article-title":"Crescents in kidney biopsy-what do they imply? A Clinicopathologic study of 40 cases in a tertiary care Center","volume":"9","author":"Chauhan","year":"2021","journal-title":"J Microsc Ultrastruct"},{"key":"2025122602500764000_ref8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3390\/ijms21020525","article-title":"A narrative review on C3 Glomerulopathy: a rare renal disease","volume":"21","author":"Schena","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025122602500764000_ref9","doi-asserted-by":"publisher","first-page":"1289812","DOI":"10.3389\/fmed.2023.1289812","article-title":"C3 glomerulopathies: dense deposit disease and C3 glomerulonephritis","volume":"10","author":"Ponticelli","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"2025122602500764000_ref10","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1046\/j.1523-1755.2003.00843.x","article-title":"Rapidly progressive crescentic glomerulonephritis","volume":"63","author":"Jennette","year":"2003","journal-title":"Kidney Int"},{"key":"2025122602500764000_ref11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000524552","article-title":"C3 Glomerulopathy: a review with emphasis on ultrastructural features","volume":"2","author":"Hou","year":"2022","journal-title":"Glomerular Dis"},{"key":"2025122602500764000_ref12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/ndt\/gfab281","article-title":"Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment","volume":"38","author":"Noris","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2025122602500764000_ref13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13000-015-0233-0","article-title":"Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience","volume":"10","author":"Viswanathan","year":"2015","journal-title":"Diagn Pathol"},{"key":"2025122602500764000_ref14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2478\/prilozi-2019-0010","article-title":"Evaluation of clinical, laboratory and treatment modalities in C3 Glomerulopathy: single Center experience","volume":"40","author":"Yeter","year":"2019","journal-title":"Pril (Makedon Akad Nauk Umet Odd Med Nauki)"}],"container-title":["Oxford Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/omcr\/article-pdf\/2025\/12\/omaf269\/66128226\/omaf269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/omcr\/article-pdf\/2025\/12\/omaf269\/66128226\/omaf269.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T07:50:14Z","timestamp":1766735414000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/omcr\/article\/doi\/10.1093\/omcr\/omaf269\/8404878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,24]]}},"URL":"https:\/\/doi.org\/10.1093\/omcr\/omaf269","relation":{},"ISSN":["2053-8855"],"issn-type":[{"value":"2053-8855","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,12]]},"article-number":"omaf269"}}